Insider · CIK 0001716950

Feinsod Matthew

Reports to the SEC for 2 companies · BERKELEY HEIGHTS, NJ

sec.gov

Transactions

Companies

Filings

CIK

0001716950

Forms 4 and 5

Insider transactions

50 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2026-03-19	KLRSKalaris Therapeutics, Inc. · Stock Option (Right to Buy)A Award	Chief Medical Officer	AAward	+135K sh	—	—	135,000
2025-04-10	KLRSKalaris Therapeutics, Inc. · Stock Option (Right to Buy)A Award	Chief Medical Officer	AAward	+101K sh	—	—	101,000
2025-04-10	KLRSKalaris Therapeutics, Inc. · Stock Option (Right to Buy)A Award	Chief Medical Officer	AAward	+70.6K sh	—	—	70,551
2025-03-18	KLRSKalaris Therapeutics, Inc. · Stock Option (right to buy)A Award	Chief Medical Officer	AAward	+28.2K sh	—	—	28,224
2025-03-18	KLRSKalaris Therapeutics, Inc.A Award	Chief Medical Officer	AAward	+4,030 sh	—	—	4,030
2019-07-29	APPLIED GENETIC TECHNOLOGIES CORPStock Option (right to buy)A Award	Exec. VP, Global Strat. & Dev.	AAward	+100K sh	—	—	100,000
2019-07-11	APPLIED GENETIC TECHNOLOGIES CORPA Award	Exec. VP, Global Strat. & Dev.	AAward	+2,000 sh	—	—	56,644
2019-07-11	APPLIED GENETIC TECHNOLOGIES CORPF Tax Payment	Exec. VP, Global Strat. & Dev.	FTax Payment	−592 sh	$3.75	−$2,220	56,052
2019-06-11	APPLIED GENETIC TECHNOLOGIES CORPA Award	Exec. VP, Global Strat. & Dev.	AAward	+2,000 sh	—	—	55,329
2019-06-11	APPLIED GENETIC TECHNOLOGIES CORPF Tax Payment	Exec. VP, Global Strat. & Dev.	FTax Payment	−685 sh	$3.77	−$2,582.45	54,644
2019-06-11	APPLIED GENETIC TECHNOLOGIES CORPF Tax Payment	Exec. VP, Global Strat. & Dev.	FTax Payment	−685 sh	$3.70	−$2,534.5	54,644
2019-05-13	APPLIED GENETIC TECHNOLOGIES CORPA Award	Exec. VP, Global Strat. & Dev.	AAward	+2,000 sh	—	—	54,014
2019-05-13	APPLIED GENETIC TECHNOLOGIES CORPF Tax Payment	Exec. VP, Global Strat. & Dev.	FTax Payment	−685 sh	$4.20	−$2,877	53,329
2019-05-13	APPLIED GENETIC TECHNOLOGIES CORPF Tax Payment	Exec. VP, Global Strat. & Dev.	FTax Payment	−685 sh	$4.06	−$2,781.1	53,329
2019-04-11	APPLIED GENETIC TECHNOLOGIES CORPA Award	Exec. VP, Global Strat. & Dev.	AAward	+2,000 sh	—	—	52,620
2019-04-11	APPLIED GENETIC TECHNOLOGIES CORPF Tax Payment	Exec. VP, Global Strat. & Dev.	FTax Payment	−606 sh	$4.61	−$2,793.66	52,014
2019-03-11	APPLIED GENETIC TECHNOLOGIES CORPA Award	Exec. VP, Global Strat. & Dev.	AAward	+2,000 sh	—	—	51,287
2019-03-11	APPLIED GENETIC TECHNOLOGIES CORPF Tax Payment	Exec. VP, Global Strat. & Dev.	FTax Payment	−667 sh	$3.97	−$2,647.99	50,620
2019-02-11	APPLIED GENETIC TECHNOLOGIES CORPA Award	Exec. VP, Global Strat. & Dev.	AAward	+2,000 sh	—	—	50,078
2019-02-11	APPLIED GENETIC TECHNOLOGIES CORPF Tax Payment	Exec. VP, Global Strat. & Dev.	FTax Payment	−791 sh	$3.29	−$2,602.39	49,287
2019-01-11	APPLIED GENETIC TECHNOLOGIES CORPA Award	Exec. VP, Global Strat. & Dev.	AAward	+2,000 sh	—	—	48,791
2019-01-11	APPLIED GENETIC TECHNOLOGIES CORPF Tax Payment	Exec. VP, Global Strat. & Dev.	FTax Payment	−713 sh	$3.20	−$2,281.6	48,078
2018-12-11	APPLIED GENETIC TECHNOLOGIES CORPF Tax Payment	Exec. VP, Global Strat. & Dev.	FTax Payment	−611 sh	$6.11	−$3,733.21	46,791
2018-12-11	APPLIED GENETIC TECHNOLOGIES CORPA Award	Exec. VP, Global Strat. & Dev.	AAward	+2,000 sh	—	—	47,402
2018-11-12	APPLIED GENETIC TECHNOLOGIES CORPF Tax Payment	Exec. VP, Global Strat. & Dev.	FTax Payment	−685 sh	$7.05	−$4,829.25	45,402
2018-11-12	APPLIED GENETIC TECHNOLOGIES CORPA Award	Exec. VP, Global Strat. & Dev.	AAward	+2,000 sh	—	—	46,087
2018-10-11	APPLIED GENETIC TECHNOLOGIES CORPF Tax Payment	Exec. VP, Global Strat. & Dev.	FTax Payment	−612 sh	$6.46	−$3,953.52	44,087
2018-10-11	APPLIED GENETIC TECHNOLOGIES CORPA Award	Exec. VP, Global Strat. & Dev.	AAward	+2,000 sh	—	—	44,699
2018-09-11	APPLIED GENETIC TECHNOLOGIES CORPF Tax Payment	Exec. VP, Global Strat. & Dev.	FTax Payment	−685 sh	$3.92	−$2,688.625	42,699
2018-09-11	APPLIED GENETIC TECHNOLOGIES CORPA Award	Exec. VP, Global Strat. & Dev.	AAward	+2,000 sh	—	—	43,384
2018-08-13	APPLIED GENETIC TECHNOLOGIES CORPF Tax Payment	Exec. VP, Global Strat. & Dev.	FTax Payment	−592 sh	$4.00	−$2,368	41,384
2018-08-13	APPLIED GENETIC TECHNOLOGIES CORPA Award	Exec. VP, Global Strat. & Dev.	AAward	+2,000 sh	—	—	41,976
2018-07-11	APPLIED GENETIC TECHNOLOGIES CORPF Tax Payment	Exec. VP, Global Strat. & Dev.	FTax Payment	−685 sh	$4.15	−$2,842.75	39,976
2018-07-11	APPLIED GENETIC TECHNOLOGIES CORPA Award	Exec. VP, Global Strat. & Dev.	AAward	+2,000 sh	—	—	40,661
2018-06-11	APPLIED GENETIC TECHNOLOGIES CORPA Award	Exec. VP, Global Strat. & Dev.	AAward	+2,000 sh	—	—	39,267
2018-06-11	APPLIED GENETIC TECHNOLOGIES CORPF Tax Payment	Exec. VP, Global Strat. & Dev.	FTax Payment	−606 sh	$4.55	−$2,757.3	38,661
2018-05-16	APPLIED GENETIC TECHNOLOGIES CORPF Tax Payment	Exec. VP, Global Strat. & Dev.	FTax Payment	−3,425 sh	$5.60	−$19.2K	37,267
2018-05-11	APPLIED GENETIC TECHNOLOGIES CORPF Tax Payment	Exec. VP, Global Strat. & Dev.	FTax Payment	−685 sh	$4.90	−$3,356.5	40,692
2018-05-11	APPLIED GENETIC TECHNOLOGIES CORPA Award	Exec. VP, Global Strat. & Dev.	AAward	+2,000 sh	—	—	41,377
2018-04-11	APPLIED GENETIC TECHNOLOGIES CORPF Tax Payment	Exec. VP, Global Strat. & Dev.	FTax Payment	−685 sh	$4.00	−$2,740	39,377
2018-04-11	APPLIED GENETIC TECHNOLOGIES CORPA Award	Exec. VP, Global Strat. & Dev.	AAward	+2,000 sh	—	—	40,062
2018-03-28	APPLIED GENETIC TECHNOLOGIES CORPA Award	Exec. VP, Global Strat. & Dev.	AAward	+10K sh	—	—	42,126
2018-03-12	APPLIED GENETIC TECHNOLOGIES CORPF Tax Payment	Exec. VP, Global Strat. & Dev.	FTax Payment	−667 sh	$4.30	−$2,868.1	32,126
2018-03-12	APPLIED GENETIC TECHNOLOGIES CORPA Award	Exec. VP, Global Strat. & Dev.	AAward	+2,000 sh	—	—	32,793
2018-02-11	APPLIED GENETIC TECHNOLOGIES CORPA Award	Exec. VP, Global Strat. & Dev.	AAward	+2,000 sh	—	—	30,793
2018-02-09	APPLIED GENETIC TECHNOLOGIES CORPA Award	Exec. VP, Global Strat. & Dev.	AAward	+2,000 sh	—	—	27,462
2018-02-09	APPLIED GENETIC TECHNOLOGIES CORPF Tax Payment	Exec. VP, Global Strat. & Dev.	FTax Payment	−733 sh	$3.95	−$2,895.35	26,729
2018-01-11	APPLIED GENETIC TECHNOLOGIES CORPF Tax Payment	Exec. VP, Global Strat. & Dev.	FTax Payment	−791 sh	$4.30	−$3,401.3	25,462
2018-01-11	APPLIED GENETIC TECHNOLOGIES CORPF Tax Payment	Exec. VP, Global Strat. & Dev.	FTax Payment	−855 sh	$4.30	−$3,676.5	28,793
2018-01-11	APPLIED GENETIC TECHNOLOGIES CORPA Award	Exec. VP, Global Strat. & Dev.	AAward	+2,000 sh	—	—	29,648

Recent filings

Accepted (ET)
Mar 204
Feinsod Matthew0001193125-26-117616
SEC(opens sec.gov)
Apr 114
Feinsod Matthew0000950170-25-053338
SEC(opens sec.gov)
Mar 184
Feinsod Matthew0000950170-25-041494
SEC(opens sec.gov)
Jul 314
Feinsod Matthew0001273636-19-000022
SEC(opens sec.gov)
Jul 154
Feinsod Matthew0001273636-19-000019
SEC(opens sec.gov)
Jun 204/A
Feinsod Matthew0001273636-19-000017
SEC(opens sec.gov)
Jun 134
Feinsod Matthew0001273636-19-000015
SEC(opens sec.gov)
May 204/A
Feinsod Matthew0001273636-19-000011
SEC(opens sec.gov)
May 154
Feinsod Matthew0001273636-19-000010
SEC(opens sec.gov)
Apr 154
Feinsod Matthew0001273636-19-000009
SEC(opens sec.gov)
Mar 134
Feinsod Matthew0001273636-19-000008
SEC(opens sec.gov)
Feb 134
Feinsod Matthew0001273636-19-000006
SEC(opens sec.gov)

Companies

Address

C/O KALARIS THERAPEUTICS, INC. 400 CONNELL DRIVE, SUITE 5500

BERKELEY HEIGHTS, NJ, 07922